Home›Companies›Biotech & Pharma›Gateway Biotechnology

Gateway Biotechnology, Inc.

Updated Oct 29, 2026·Latest SEC filing Jun 5, 2025·Suggest an edit

About Gateway Biotechnology

Gateway Biotechnology is a private company based in Durham, North Carolina. It has reported $633,000 raised in one offering on Form D since June 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 22, 2025Jun 5, 2025$633,000of $2.4M target4$158KSimple Agreement for Future Equity (SAFE) offering a 20% discount on future equity.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Gateway Biotechnology's Form D filed Jun 5, 2025.

JB
Jianxin Bao
Executive officer
PP
Philip Perez
Director
RC

Sources

  1. SECGateway Biotechnology, Inc. filing history